Genprex Inc (NASDAQ:GNPX) does about 529.63K shares in volume on a normal day but saw 5916556 shares change hands in the recent trading day. The company now has a market cap of 1.07M USD. Its current market price is $0.41, marking an increase of 21.51% compared to the previous close of $0.34. The 52 week high reached by this stock is $14.80 whilst the lowest price level in 52 weeks is $0.28.
Genprex Inc (GNPX) has a 20-day trading average at $0.3552 and the current price is -97.21% off the 52-week high compared with 47.18% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5167 and its 200-day simple moving average is $2.8874. If we look at the stock’s price movements over the week, volatility stands at 18.93%, which decreases to 11.05% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 48.32 to suggest the stock is neutral.
The consensus objective for the share price is $7.50, suggesting that the stock has a potential upside of 94.53% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 26, 2021 when National Securities initiated the stock to “Buy” and issued a price target of $7.
The current price level is 16.29%, -20.07%, and -85.70% away from its SMA20, SMA50, and SMA200 respectively, with the GNPX price moving above the 50-day SMA on current market day. Genprex Inc (GNPX) stock is up 21.90% over the week and 5.90% over the past month. Its price is -95.51% year-to-date and -96.80% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of -5.2 below consensus estimates by -0.8. The company’s next earnings report forecasts estimating quarterly EPS at -1.93 and -5.62 for whole year.
To reach the target analysts have set, the stock logically needs to grow 94.53 percent from here.
The company has a return on investment of -601.59% and return on equity of -318.88%. The beta has a value of -0.58. Price to book ratio is 0.24.
